Arpesh Mehta
Investment Director @ DSM Venturing
New York, United States
Arpesh Mehta is a Series A investor at DSM Venturing in New York focused on Fuel and Energy. Mr. Arpesh Mehta served as a Senior Research Associate of Ceregene. Mr. Mehta is playing an integral role in the development and IND submission for an Alzheimer’s disease therapeutic, and worked on the preclinical development of a gene therapy product in clinical trials. Mr. Mehta worked on numerous investments in the clean technology andbiotechnology sectors, being involved with all stages of the investment process from evaluating investment prospects to board governance. Mr. Mehta's cleantech investment involvement includes Virent, EcoSynthetix, Aspectrics (acquired by Guided Wave), BrightSource Energy, and Sindicatum Renewable Resources. Prior to Black River, Mr. Mehta held various R&D and marketing positions in the biotech industry. He worked as a staff researcher at the Geffen School of Medicine at UCLA, where he published numerous papers on the characterization of potential drug targets and has presented his research at international conferences. In addition, Mr. Mehta was a summer marketing intern at Genentech. His experience spans multiple functions within life science. He serves as a Director at Cargill Ventures and Black River Asset Management. He serves as a Director of Prometheus Energy Company. He serves as Observer of Alvine Pharmaceuticals, Inc. He received an M.B.A. from the Kellogg School at Northwestern University, an M.S. in Biomedical Engineering from UCLA, and a B.A. in Biology from the University of Pennsylvania.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Arpesh Mehta invests in
Stages Arpesh Mehta invests in
Countries Arpesh Mehta invests in
Investment Focus
Industry
- Fuel 1 (33%)
- Energy 1 (33%)
- Hospital 1 (33%)
- Health Care 1 (33%)
- Oil and Gas 1 (33%)
Stage
- Series A 2 (67%)
- Funding Round 1 (33%)
Country
- United States 2 (67%)
- Canada 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Enhanced Medical Nutrition
|
Enhanced Medical Nutrition builds clinical nutrition products to help patients prepare better and recover faster from surgery. | $5M / Series A / Jan 14, 2025 | |
Alvine Pharmaceuticals
|
Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease. | $21.5M / Series A / Sep 11, 2006 | |
Prometheus Energy
|
Prometheus Energy works with partners across a range of fuel-intensive sectors to provide them with lower-cost, lower-carbon, integrated energy solutions in way of natural gas (in liquid form) from waste and conventional sources. Prometheus is privately owned by Shell Technology Venture Fund and Black River Asset Management Fund (wholly owned byCargill). | $20M |
Co-Investors
About DSM Venturing
Founded in 2002, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.
DSM Venturing Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Akshat Kshetrapal
Investment Director
|
|||
|
Arpesh Mehta
Investment Director
|
|||
Greg McParland
Investment Director
|
|||
Iulian Baxan
Analyst
|
|||
Luda Kopeikina
Investment Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Arpesh Mehta invest in?
Arpesh Mehta invests primarily in Fuel, Energy and Hospital startups, most often at Series A and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Arpesh Mehta last invest?
The most recent investment recorded for Arpesh Mehta closed in Jan 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
